Expert Review of Neurotherapeutics

Papers
(The H4-Index of Expert Review of Neurotherapeutics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis42
The latest developments with internet-based psychological treatments for depression39
Steps to manage treatment-refractory migraine in adults39
Where Art Thou O treatment for diabetic neuropathy: the sequel36
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease33
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study31
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review29
The relevance of cortical thickness in migraine sufferers and implications to therapy27
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms27
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives26
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options25
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?25
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202523
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents22
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men22
Advances in the treatment and management of frontotemporal dementia22
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis22
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia22
Why is ADHD so difficult to diagnose in older adults?21
Acute and long-term cognitive impairment following sepsis: mechanism and prevention21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead21
0.40753293037415